Defining the disulfide bonds of insulin-like growth factor-binding protein-5 by tandem mass spectrometry with electron transfer dissociation and collision-induced dissociation

Journal of Biological Chemistry

Volumn 287, Issue 2, 2012, Pages 1510-1519

  Nili, Mahta ^a   Mukherjee, Aditi ^a   Shinde, Ujwal ^a   David, Larry ^a   Rotwein, Peter ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AB INITIO MOLECULAR MODELING; BIOLOGICAL EFFECTS; CHEMICAL REDUCTION; COLLISION-INDUCED DISSOCIATION; DISULFIDE BONDS; DISULFIDE LINKAGES; ELECTRON-TRANSFER DISSOCIATION; GENERAL APPROACH; PREDICTIVE POWER; SECRETED MOLECULES; SIGNALING RECEPTOR; TANDEM MASS SPECTROMETRY; TANDEM MS; TERMINAL DOMAIN;

AMINO ACIDS; COVALENT BONDS; ELECTRON AFFINITY; ELECTRON TRANSITIONS; INSULIN; MASS SPECTROMETRY; MOLECULAR MODELING; PEPTIDES;

DISSOCIATION;

CYSTEINE; SOMATOMEDIN BINDING PROTEIN 5;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; COLLISIONALLY ACTIVATED DISSOCIATION; CONTROLLED STUDY; DISSOCIATION; DISULFIDE BOND; ELECTRON TRANSFER DISSOCIATION; ELECTRON TRANSPORT; FOREST FRAGMENTATION; MOLECULAR MODEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN CROSS LINKING; PROTEIN DOMAIN; PROTEIN MOTIF; TANDEM MASS SPECTROMETRY;

AMINO ACID MOTIFS; ANIMALS; CELL LINE; CYSTEINE; DISULFIDES; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 5; MASS SPECTROMETRY; MICE; MODELS, MOLECULAR; PEPTIDE MAPPING;

EID: 84855516916     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.285528     Document Type: Article

References (52)

1. Nakae,J., Kido,Y., and Accili,D. (2001) Distinct and overlapping functions of insulin and IGF-I receptors. Endocr. Rev. 22, 818-835
2. Samani,A. A., Yakar,S., LeRoith,D., and Brodt,P. (2007) The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr. Rev. 28, 20-47
3. Maki,R. G. (2010) Small is beautiful: insulin-like growth factors and their role in growth, development, and cancer. J. Clin. Oncol. 28, 4985-4995
4. Clemmons,D. R. (1998) Role of insulin-like growth factor binding proteins in controlling IGF actions. Mol. Cell Endocrinol. 140, 19-24
5. Mohan,S., and Baylink,D. J. (2002) IGF-binding proteins are multifunctional and act via IGF-dependent and -independent mechanisms. J. Endocrinol. 175, 19-31
6. Daza,D. O., Sundström,G., Bergqvist,C. A., Duan,C., and Larhammar,D. (2011) Evolution of the insulin-like growth factor binding protein (IGFBP) family. Endocrinology 152, 2278-2289
7. Bach,L. A., Headey,S. J., and Norton,R. S. (2005) IGF-binding proteins - the pieces are falling into place. Trends Endocrinol. Metab. 16, 228-234
8. Hwa,V., Oh,Y., and Rosenfeld,R. G. (1999) The insulin-like growth factor- binding protein (IGFBP) superfamily. Endocr. Rev. 20, 761-787
9. Firth,S. M., and Baxter,R. C. (2002) Cellular actions of the insulin-like growth factor binding proteins. Endocr. Rev. 23, 824-854
10. Zhou,R., Diehl,D., Hoeflich,A., Lahm,H., and Wolf,E. (2003) IGF-binding protein-4: biochemical characteristics and functional consequences. J. Endocrinol. 178, 177-193
11. Neumann,G. M., and Bach,L. A. (1999) The N-terminal disulfide linkages of human insulin-like growth factor-binding protein-6 (hIGFBP-6) and hIGFBP-1 are different as determined by mass spectrometry. J. Biol. Chem. 274, 14587-14594
12. Sitar,T., Popowicz,G. M., Siwanowicz,I., Huber,R., and Holak,T. A. (2006) Structural basis for the inhibition of insulin-like growth factors by insulin-like growth factor-binding proteins. Proc. Natl. Acad. Sci. U.S.A. 103, 13028-13033
13. Sala,A., Capaldi,S., Campagnoli,M., Faggion,B., Labò,S., Perduca,M., Romano,A., Carrizo,M. E., Valli,M., Visai,L., Minchiotti,L., Galliano,M., and Monaco,H. L. (2005) Structure and properties of the C-terminal domain of insulin-like growth factor-binding protein-1 isolated from human amniotic fluid. J. Biol. Chem. 280, 29812-29819
14. Siwanowicz,I., Popowicz,G. M., Wisniewska,M., Huber,R., Kuenkele,K. P., Lang,K., Engh,R. A., and Holak,T. A. (2005) Structural basis for the regulation of insulin-like growth factors by IGF binding proteins. Structure 13, 155-167
15. Fernández-Tornero,C., Lozano,R. M., Rivas,G., Jiménez,M. A., Ständker,L., Díaz-Gonzalez,D., Forssmann,W. G., Cuevas,P., Romero,A., and Giménez-Gallego,G. (2005) Synthesis of the blood circulating C-terminal fragment of insulin-like growth factor (IGF)-binding protein-4 in its native conformation. Crystallization, heparin and IGF binding, and osteogenic activity. J. Biol. Chem. 280, 18899-18907
16. Beattie,J., Allan,G. J., Lochrie,J. D., and Flint,D. J. (2006) Insulin-like growth factor-binding protein-5 (IGFBP-5): a critical member of the IGF axis. Biochem. J. 395, 1-19
17. Schneider,M. R., Wolf,E., Hoeflich,A., and Lahm,H. (2002) IGF-binding protein-5: flexible player in the IGF system and effector on its own. J. Endocrinol. 172, 423-440
18. James,P. L., Jones,S. B., Busby,W. H., Jr., Clemmons,D. R., and Rotwein,P. (1993) A highly conserved insulin-like growth factor-binding protein (IGFBP-5) is expressed during myoblast differentiation. J. Biol. Chem. 268, 22305-22312
19. Conover,C. A. (2008) Insulin-like growth factor-binding proteins and bone metabolism. Am. J. Physiol. Endocrinol. Metab. 294, E10-E14
20. Mukherjee,A., and Rotwein,P. (2007) Insulin-like growth factor binding protein-5 in osteogenesis: facilitator or inhibitor? Growth Horm. IGF Res. 17, 179-185
21. Mukherjee,A., and Rotwein,P. (2008) Insulin-like growth factor-binding protein-5 inhibits osteoblast differentiation and skeletal growth by blocking insulin-like growth factor actions. Mol. Endocrinol. 22, 1238-1250
22. Salih,D. A., Mohan,S., Kasukawa,Y., Tripathi,G., Lovett,F. A., Anderson,N. F., Carter,E. J., Wergedal,J. E., Baylink,D. J., and Pell,J. M. (2005) Insulin-like growth factor-binding protein-5 induces a gender-related decrease in bone mineral density in transgenic mice. Endocrinology 146, 931-940
23. Cobb,L. J., Salih,D. A., Gonzalez,I., Tripathi,G., Carter,E. J., Lovett,F., Holding,C., and Pell,J. M. (2004) Partitioning of IGFBP-5 actions in myogenesis: IGF-independent anti-apoptotic function. J. Cell Sci. 117, 1737-1746
24. Mukherjee,A., Wilson,E. M., and Rotwein,P. (2008) Insulin-like growth factor (IGF) binding protein-5 blocks skeletal muscle differentiation by inhibiting IGF actions. Mol. Endocrinol. 22, 206-215
25. Ning,Y., Schuller,A. G., Bradshaw,S., Rotwein,P., Ludwig,T., Frystyk,J., and Pintar,J. E. (2006) Diminished growth and enhanced glucose metabolism in triple knockout mice containing mutations of insulin-like growth factor binding protein-3, -4, and -5. Mol. Endocrinol. 20, 2173-2186
26. Salih,D. A., Tripathi,G., Holding,C., Szestak,T. A., Gonzalez,M. I., Carter,E. J., Cobb,L. J., Eisemann,J. E., and Pell,J. M. (2004) Insulin-like growth factor-binding protein 5 (Igfbp5) compromises survival, growth, muscle development, and fertility in mice. Proc. Natl. Acad. Sci. U.S.A. 101, 4314-4319
27. Ren,H., Yin,P., and Duan,C. (2008) IGFBP-5 regulates muscle cell differentiation by binding to IGF-II and switching on the IGF-II auto-regulation loop. J. Cell Biol. 182, 979-991
28. Hise,M. K., Mantzouris,N. M., Lahn,J. S., Sheikh,M. S., Shao,Z. M., and Fontana,J. A. (1994) IGF binding protein 5 and IGF-I receptor regulation in hypophysectomized rat kidneys. Am. J. Physiol. 266, F147-154
29. Gleason,C. E., Ning,Y., Cominski,T. P., Gupta,R., Kaestner,K. H., Pintar,J. E., and Birnbaum,M. J. (2010) Role of insulin-like growth factor-binding protein 5 (IGFBP5) in organismal and pancreatic beta-cell growth. Mol. Endocrinol. 24, 178-192
30. Kim,K. S., Seu,Y. B., Baek,S. H., Kim,M. J., Kim,K. J., Kim,J. H., and Kim,J. R. (2007) Induction of cellular senescence by insulin-like growth factor binding protein-5 through a p53-dependent mechanism. Mol. Biol. Cell 18, 4543-4552
31. Sorrell,A. M., Shand,J. H., Tonner,E., Gamberoni,M., Accorsi,P. A., Beattie,J., Allan,G. J., and Flint,D. J. (2006) Insulin-like growth factor-binding protein-5 activates plasminogen by interaction with tissue plasminogen activator, independently of its ability to bind to plasminogen activator inhibitor-1, insulin-like growth factor-I, or heparin. J. Biol. Chem. 281, 10883-10889
32. Tripathi,G., Salih,D. A., Drozd,A. C., Cosgrove,R. A., Cobb,L. J., and Pell,J. M. (2009) IGF-independent effects of insulin-like growth factor binding protein-5 (Igfbp5) in vivo. FASEB J. 23, 2616-2626
33. Yasuoka,H., Yamaguchi,Y., and Feghali-Bostwick,C. A. (2009) The profibrotic factor IGFBP-5 induces lung fibroblast and mononuclear cell migration. Am. J. Respir. Cell Mol. Biol. 41, 179-188
34. Zeslawski,W., Beisel,H. G., Kamionka,M., Kalus,W., Engh,R. A., Huber,R., Lang,K., and Holak,T. A. (2001) The interaction of insulin-like growth factor-I with the N-terminal domain of IGFBP-5. EMBO J. 20, 3638-3644
35. Imai,Y., Moralez,A., Andag,U., Clarke,J. B., Busby,W. H., Jr., and Clemmons,D. R. (2000) Substitutions for hydrophobic amino acids in the N-terminal domains of IGFBP-3 and -5 markedly reduce IGF-I binding and alter their biologic actions. J. Biol. Chem. 275, 18188-18194
36. Kalus,W., Zweckstetter,M., Renner,C., Sanchez,Y., Georgescu,J., Grol,M., Demuth,D., Schumacher,R., Dony,C., Lang,K., and Holak,T. A. (1998) Structure of the IGF-binding domain of the insulin-like growth factor-binding protein-5 (IGFBP-5): implications for IGF and IGF-I receptor interactions. EMBO J. 17, 6558-6572
37. Shand,J. H., Beattie,J., Song,H., Phillips,K., Kelly,S. M., Flint,D. J., and Allan,G. J. (2003) Specific amino acid substitutions determine the differential contribution of the N- and C-terminal domains of insulin-like growth factor (IGF)-binding protein-5 in binding IGF-I. J. Biol. Chem. 278, 17859-17866
38. Mamathambika,B. S., and Bardwell,J. C. (2008) Disulfide-linked protein folding pathways. Annu. Rev. Cell Dev. Biol. 24, 211-235
39. Wu,S. L., Jiang,H., Hancock,W. S., and Karger,B. L. (2010) Identification of the unpaired cysteine status and complete mapping of the 17 disulfides of recombinant tissue plasminogen activator using LC-MS with electron transfer dissociation/collision induced dissociation. Anal. Chem. 82, 5296-5303
40. Wu,S. L., Jiang,H., Lu,Q., Dai,S., Hancock,W. S., and Karger,B. L. (2009) Mass spectrometric determination of disulfide linkages in recombinant therapeutic proteins using online LC-MS with electron-transfer dissociation. Anal. Chem. 81, 112-122
41. Wiesner,J., Premsler,T., and Sickmann,A. (2008) Application of electron transfer dissociation (ETD) for the analysis of posttranslational modifications. Proteomics 8, 4466-4483
42. Chrisman,P. A., Pitteri,S. J., Hogan,J. M., and McLuckey,S. A. (2005) SO2-*electron transfer ion/ion reactions with disulfide linked polypeptide ions. J. Am. Soc. Mass Spectrom 16, 1020-1030
43. Mikesh,L. M., Ueberheide,B., Chi,A., Coon,J. J., Syka,J. E., Shabanowitz,J., and Hunt,D. F. (2006) The utility of ETD mass spectrometry in proteomic analysis. Biochim. Biophys. Acta 1764, 1811-1822
44. Gorman,J. J., Wallis,T. P., and Pitt,J. J. (2002) Protein disulfide bond determination by mass spectrometry. Mass Spectrom Rev. 21, 183-216
45. Humphries,J. D., Byron,A., Bass,M. D., Craig,S. E., Pinney,J. W., Knight,D., and Humphries,M. J. (2009) Proteomic analysis of integrin-associated complexes identifies RCC2 as a dual regulator of Rac1 and Arf6. Sci. Signal 2, ra51
46. Keshamouni,V. G., Jagtap,P., Michailidis,G., Strahler,J. R., Kuick,R., Reka,A. K., Papoulias,P., Krishnapuram,R., Srirangam,A., Standiford,T. J., Andrews,P. C., and Omenn,G. S. (2009) Temporal quantitative proteomics by iTRAQ 2D-LC-MS/MS and correspondingmRNAexpression analysis identify post-transcriptional modulation of actin-cytoskeleton regulators during TGF-beta-Induced epithelial-mesenchymal transition. J. Proteome Res. 8, 35-47
47. Bonneau,R., Strauss,C. E., Rohl,C. A., Chivian,D., Bradley,P., Malmstrom,L., Robertson,T., and Baker,D. (2002) De novo prediction of threedimensional structures for major protein families. J. Mol. Biol. 322, 65-78
48. Schwede,T., Kopp,J., Guex,N., and Peitsch,M. C. (2003) SWISS-MODEL: An automated protein homology-modeling server. Nucleic Acids Res. 31, 3381-3385
49. Forbes,B. E., Turner,D., Hodge,S. J., McNeil,K. A., Forsberg,G., and Wallace,J. C. (1998) Localization of an insulin-like growth factor (IGF) binding site of bovine IGF binding protein-2 using disulfide mapping and deletion mutation analysis of the C-terminal domain. J. Biol. Chem. 273, 4647-4652
50. Osaki,T., Sasaki,K., and Minamino,N. (2011) Peptidomics-based discovery of an antimicrobial peptide derived from insulin-like growth factor-binding protein 5. J. Proteome Res. 10, 1870-1880
51. Fleishman,S. J., Corn,J. E., Strauch,E. M., Whitehead,T. A., Karanicolas,J., and Baker,D. (2011) J. Mol. Biol.
52. Khatib,F., DiMaio,F., Cooper,S., Kazmierczyk,M., Gilski,M., Krzywda,S., Zabranska,H., Pichova,I., Thompson,J., Popovi,Z., Jaskolski,M., and Baker,D. (2011) Crystal structure of a monomeric retroviral protease solved by protein folding game players. Nat. Struct. Mol. Biol. 18, 1175-1177